Blueprint Medicines Equity Dashboard

Blueprint Medicines Corporation -- USA Stock  

USD 87.57  0.75  0.85%

The Equities Center is a collection of modules for individual equity research and analysis. You can examine different market driven as well as company specific characteristics using powerful cross-assets modules such as watch-list analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerful tools. Please select from the options below.
Quote & Profile

Quote & Profile

Blueprint Medicines profile, quote, and daily performance
Earnings Buzz

Earnings Buzz

Historical and projected earnings estimates for Blueprint Medicines
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for Blueprint Medicines
Event Calendar

Event Calendar

Calendar of corporate events and headlines for Blueprint Medicines
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for Blueprint Medicines
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for Blueprint Medicines
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for Blueprint Medicines
Chance of Bankruptcy

Chance of Bankruptcy

Blueprint Medicines chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different Blueprint Medicines historical pattern-recognition indicators
Current Valuation

Current Valuation

Blueprint Medicines valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

Blueprint Medicines current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze Blueprint Medicines Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

Blueprint Medicines volatility and risk analysis compared to market
Correlation With Market

Correlation With Market

Blueprint Medicines correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

Blueprint Medicines in the context of related companies
Management

Management

Blueprint Medicines leadership and management evaluation
Performance

Performance

Risk adjusted expected returns and performance analysis
Risk-adjusted Recommendation

Risk-adjusted Recommendation

Personalized buy or sell advice on Blueprint Medicines
Power Widgets

Power Widgets

Macroaxis widgets syndication for Blueprint Medicines
Price Prediction

Price Prediction

Basic Blueprint Medicines price forecast based on headlines and hype
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for Blueprint Medicines
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of Blueprint Medicines
Fundamental History

Fundamental History

Blueprint Medicines history of fundamentals from various financial
Revenue

Revenue

Relative Blueprint Medicines revenue analysis
Net Loss Analysis

Net Loss Analysis

Blueprint Medicines loss analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on Blueprint Medicines operations
Balance Of Power

Balance Of Power

Daily balance of power indicator of Blueprint Medicines
Semi-Deviation

Semi-Deviation

Current Semi-Deviation of Blueprint Medicines
Price History

Price History

Blueprint Medicines daily price history and news impact
Pair Correlation

Pair Correlation

Correlation analysis between Blueprint Medicines and NantKwest
BPMC vs. DMPI

BPMC vs. DMPI

Fundamentals comparison between Blueprint Medicines and Del Mar
This is a quick snapshot of Blueprint Medicines research areas. You can expand your research by examining different market driven as well as company specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and and many other powerfull tools.